Spectrum Wars: How AST SpaceMobile Became the Poison Pill Legacy Players Can't Escape episode artwork

EPISODE · Jul 1, 2026 · 54 MIN

Spectrum Wars: How AST SpaceMobile Became the Poison Pill Legacy Players Can't Escape

from AST SpaceMobile Podcast · host SpaceMob

What does it take to hold a stock from $2 to $130? According to Anpanman, it takes a special kind of delusion — and he means that as the highest possible compliment. In this episode, Anpanman fires up a wide-ranging conversation about the mental fortitude required to invest in the space sector before it was cool, why the critics and short sellers who tried to sabotage AST SpaceMobile ultimately ended up benefiting from the very company they attacked, and what the summer of 2025 could mean for long-term believers in the thesis.Anpanman breaks down the fascinating and often ironic story of legacy satellite players — Viasat, Iridium, and Globalstar — who spent years pooh-poohing the direct-to-device concept, only to find their spectrum holdings dramatically revalued because of AST's pioneering work. He walks through the Ligado deal, Viasat's failed attempts to unscramble the egg in bankruptcy court, and why AST's 80-year L-band rights in North America function as an effective poison pill for any competitor hoping to build a global constellation without the most profitable market in the world anchoring the economics.The episode goes deep on the summer catalyst setup, including the J-LEO project timeline with Rakuten, the expected delivery and launch of Bluebird satellites 11 through 13, a potential multi-launch agreement with Mitsubishi Heavy, and the strategic implications of the grain management 800 MHz spectrum development that AST publicly supported. Anpanman also connects the dots on how Starlink's increasingly aggressive moves into terrestrial mobile are paradoxically accelerating AST's strategic value with carriers like KDDI, NTT DoCoMo, and SoftBank around the world.This is one of the most comprehensive state-of-the-union conversations on the AST SpaceMobile thesis available right now. Whether you're a long-term holder looking for conviction reinforcement or a newer investor trying to understand the full strategic picture, Anpanman delivers the context, history, and forward-looking analysis you need. Don't miss it — and if you believe in the mission, share this episode with someone who still thinks the idea is crazy.00:26 Introduction & Technical Issues01:26 Being Called Delusional: A Badge of Honor for Space Investors03:26 Legacy Player Revival: Viasat, Iridium, and Globalstar's Spectrum Value07:56 The Ligado Deal and Spectrum Alchemy Explained14:26 Rocket Lab Acquires Iridium: What It Means for Innovation23:26 Summer Catalyst Setup: J-LEO, Bluebirds, and T-Mobile33:26 The Federated Constellation Model and Global JV Playbook50:26 Grain Management 800 MHz Spectrum and AST's FCC Support Letter

Episode metadata supplied by the publisher feed · Published Jul 1, 2026

Embed this episode

NOW PLAYING

Spectrum Wars: How AST SpaceMobile Became the Poison Pill Legacy Players Can't Escape

0:00 54:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AST SpaceMobile Podcast?

This episode is 54 minutes long.

When was this AST SpaceMobile Podcast episode published?

This episode was published on July 1, 2026.

Can I download this AST SpaceMobile Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!